Management of Dyslipidemia
About this episode
The episode discusses the ACC/AHA guideline on the management of dyslipidemia and its implications for cardiovascular disease.
Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of global mortality and is strongly associated with cumulative exposure to atherogenic lipoproteins across the lifespan. Author Amber E. Johnson, MD, MS, MBA, of the University of Chicago joins JAMA Senior Editor Philip Greenland, MD, to discuss the ACC/AHA guideline on management of dyslipidemia. Related Content: Dyslipidemia Evaluation and Management Implications of the 2026 Dyslipidemia Guideline for Primary Prevention Statin Therapy
More episodes of JAMA Clinical Reviews
- Rheumatoid Arthritis
- An Overview of Postural Orthostatic Tachycardia Syndrome (POTS)
- Medication Treatments for Alcohol Use Disorder
- Liquid Biopsy Tests for Cancer
- Patient-Clinician Communication About Physical Activity
- Classic Hodgkin Lymphoma
Explore listener stats, chart rankings, contacts and more on the JAMA Clinical Reviews podcast page.